Dilling MB - Search Results

1

Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1).

Huang S, Shu L, Dilling MB, Easton J, Harwood FC, Ichijo H, Houghton PJ. Huang S, et al. Among authors: dilling mb. Mol Cell. 2003 Jun;11(6):1491-501. doi: 10.1016/s1097-2765(03)00180-1. Mol Cell. 2003. PMID: 12820963 Free article.

2

4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin.

Dilling MB, Germain GS, Dudkin L, Jayaraman AL, Zhang X, Harwood FC, Houghton PJ. Dilling MB, et al. J Biol Chem. 2002 Apr 19;277(16):13907-17. doi: 10.1074/jbc.M110782200. Epub 2002 Feb 14. J Biol Chem. 2002. PMID: 11847216 Free article.

3

Studies on the mechanism of resistance to rapamycin in human cancer cells.

Hosoi H, Dilling MB, Liu LN, Danks MK, Shikata T, Sekulic A, Abraham RT, Lawrence JC Jr, Houghton PJ. Hosoi H, et al. Among authors: dilling mb. Mol Pharmacol. 1998 Nov;54(5):815-24. doi: 10.1124/mol.54.5.815. Mol Pharmacol. 1998. PMID: 9804616

4

Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.

Hosoi H, Dilling MB, Shikata T, Liu LN, Shu L, Ashmun RA, Germain GS, Abraham RT, Houghton PJ. Hosoi H, et al. Among authors: dilling mb. Cancer Res. 1999 Feb 15;59(4):886-94. Cancer Res. 1999. PMID: 10029080

5

p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.

Huang S, Liu LN, Hosoi H, Dilling MB, Shikata T, Houghton PJ. Huang S, et al. Among authors: dilling mb. Cancer Res. 2001 Apr 15;61(8):3373-81. Cancer Res. 2001. PMID: 11309295

6

Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor.

Dilling MB, Dias P, Shapiro DN, Germain GS, Johnson RK, Houghton PJ. Dilling MB, et al. Cancer Res. 1994 Feb 15;54(4):903-7. Cancer Res. 1994. PMID: 7508822

7

Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition.

Dudkin L, Dilling MB, Cheshire PJ, Harwood FC, Hollingshead M, Arbuck SG, Travis R, Sausville EA, Houghton PJ. Dudkin L, et al. Among authors: dilling mb. Clin Cancer Res. 2001 Jun;7(6):1758-64. Clin Cancer Res. 2001. PMID: 11410517

8

The molecular basis of skeletal muscle differentiation.

Dias P, Dilling M, Houghton P. Dias P, et al. Semin Diagn Pathol. 1994 Feb;11(1):3-14. Semin Diagn Pathol. 1994. PMID: 8202645 Review.

9

The influence of recombinant human insulin-like growth factor-I (rhIGF-I) on cell growth and cytotoxicity of drugs in childhood rhabdomyosarcoma cell lines and xenograft models.

Gidding CE, Germain GS, Dilling MB, Meeuwsen-de Boer TG, Ashmun RA, de Graaf SS, Veverka KA, Kamps WA, Houghton PJ. Gidding CE, et al. Among authors: dilling mb. Cancer Chemother Pharmacol. 2000;45(1):21-30. doi: 10.1007/PL00006738. Cancer Chemother Pharmacol. 2000. PMID: 10647497

10

Rapamycin inhibits substance P-induced protein synthesis and phosphorylation of PHAS-I (4E-BP1) and p70 S6 kinase (p70(S6K)) in human astrocytoma cells.

Sharif M, Sharif T, Dilling M, Hosoi H, Lawrence J, Houghton P. Sharif M, et al. Int J Oncol. 1997 Oct;11(4):797-805. doi: 10.3892/ijo.11.4.797. Int J Oncol. 1997. PMID: 21528277

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page